Ashwagandha bio gélules
Food supplement declared in France, declaration No 2020-6-176, decision dated 4 June 2020
Ashwagandha bio gélules (JOLIVIA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 600 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- JOLIVIA
- Food business operator placing the product on the market
- AWWAOU
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 600 mg
- Directions for use
- Prendre 1 à 2 gélules par jour avec un verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Taking thyroid medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep, Mood
Declaration 169129, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Withania somnifera (L.) Dunal | Racine | Poudre (de plantes séchées ou broyées) | 600 mg |
Additives
Hydroxypropyl Méthyl Cellulose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux femmes enceintes ou allaitantes, aux personnes sujettes à l’hyperthyroïdie.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Ashwagandha bio gélules Christine Elisbeth Irnstetter, declared in 2023 : different composition: 0 ingredient(s) added, 1 missing
- Ashwagandha bio gélules Flügelschwinger, declared in 2023 : different composition: 0 ingredient(s) added, 1 missing
Brand : JOLIVIA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ashwagandha bio gélules (JOLIVIA): composition and regulation”, https://compoatlas.com/en/supplements/products/169129-ashwagandha-bio-gelules, updated 15 November 2026.